-
Six Practices of High Performing Clinical Research Sites
fiercebiotech
December 25, 2018
Clinical research sites have a tough, but critically important, job. We need research sites to help us develop and test new therapies, and to bring new treatments to patients. It’s rigorous and precise work, but essential to the progress of medicine....
-
CX Partners acquires equity stake in Veeda Clinical Research
expressbpd
December 17, 2018
CX Partners acquires equity stake in Veeda Clinical Research
-
PPD Adds New Therapeutic Area Leaders
contractpharma
December 14, 2018
PPD has appointed Darell Heiselman, D.O., to lead cardiovascular and critical care and David Klein, M.D., Ph.D., to oversee endocrinology, metabolism and diabetes.
-
Intellia’s clinical head moves to CRISPR-focused Casebia to be its first CMO
fiercebiotech
November 02, 2018
Intellia Therapeutics’ head of clinical development, Adel Nada, M.D., has left the gene-editing hopeful to serve as the first chief medical officer of Casebia Therapeutics, a joint venture launched by ...
-
PharmaTimes International Clinical Researcher of the Year 2019 is open for entry
pharmatimes
October 12, 2018
The PharmaTimes International Clinical Researcher of the Year competition is now open for entry, flying the flag for excellence in global clinical research for its 20th year.
-
Takeda's lung cancer treatment Alunbrig proves successful in Phase III trial
pharmafile
September 27, 2018
Japanese pharma firm Takeda have announced that lung cancer treatment Alunbrig has proven successful in reducing the risk of disease progression or death by more than 50%...
-
CISCRP releases a video to improve diversity in clinical research
biospectrum
September 20, 2018
With support from Janssen Research & Development, Pharmaceutical Companies of Johnson & Johnson, CISCRP customized a recreational vehicle called "Journey to Better Health" that visited 10 different Los Angeles community events.
-
Bristol-Myers Squibb begins phase 3 enrollment after psoriasis drug shows high skin clearance
fiercebiotech
September 13, 2018
Two-thirds to three-quarters of patients taking 3 mg twice daily or more showed at least 75% skin clearance after 12 weeks, compared to 7% taking placebo.
-
FSD Pharma, SciCann Launch clinical research program in Israel
biospectrumasia
August 20, 2018
Under the strategic alliance agreement with Mor, FSD Pharma and SciCann will execute a series of rigorous, randomized, placebo-controlled clinical studies to demonstrate the safety and efficacy of the products
-
NIHR launches new standards for public involvement in research
pharmatimes
July 23, 2018
The National Institute for Health Research (NIHR) has launched a new set of national standards for public involvement in clinical research for use by organisations across the UK.